Carolyn D. Runowicz, MD

Florida International University Herbert Whertheim College of Medicine

RunowiczCarolyn D. Runowicz, MD is a nationally and internationally recognized leader in women’s health and gynecologic cancer. Her research has focused on the development, initiation and conduct of clinical trials in gynecologic cancer and in cancer prevention. She has authored more than 200 scientific articles.

She has received numerous honors and awards, including the University of Connecticut Distinguished Alumni Award, the American Medical Women’s Association Local Legend Award, Cancer Care Physician of the Year Award, and the American Society of Clinical Oncology Statesman Award.

She has served in leadership roles in the major cancer organizations. She served as the first woman president of the Society of Gynecologic Oncologists (2000), was President of the American Cancer Society (2005) and served on the National Cancer Advisory Board (NCAB), appointed by President George W. Bush. She served as Chair of the NCAB for 4 years (2006-2010). She is currently serving on the Board of Directors of the American Society of Clinical Oncology (2011-2015) and as Vice President of the American Gynecological and Obstetrical Foundation Board.

She has served on numerous committees for the Society of Gynecologic Oncologists, American College of Obstetricians and Gynecologists, American Cancer Society, the National Cancer Institute, the National Surgical Adjuvant Breast and Bowel Project, the American Society of Clinical Oncology and the American Gynecologic and Obstetrical Society.

She is a reviewer for medical journals and serves on several editorial boards in recognition of her expertise in women’s health and gynecologic cancers. She is on several scientific advisory boards, including the National Cancer Institute and the Ovarian Cancer Research Foundation.

Spotlight

Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.

Awareness

Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.

Research

The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.

Education

The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.